Intermittent hypoxia-induced downregulation of microRNA-320b promotes lung cancer tumorigenesis by increasing CDT1 via USP37
Open Access
- 31 December 2020
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy Nucleic Acids
- Vol. 24, 528-541
- https://doi.org/10.1016/j.omtn.2020.12.023
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Serum levels of miR-320 family members are associated with clinical parameters and diagnosis in prostate cancer patientsOncotarget, 2017
- Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non–Small Cell Lung Cancer Using Next-Generation SequencingClinical Cancer Research, 2017
- Low expression of microRNA-320b correlates with tumorigenesis and unfavorable prognosis in gliomaOncology Reports, 2017
- miR-320b suppresses cell proliferation by targeting c-Myc in human colorectal cancer cellsBMC Cancer, 2015
- The expression of hypoxia-inducible factor-1α and its clinical significance in lung cancer: a systematic review and meta-analysisSwiss Medical Weekly, 2013
- CXCR2 Macromolecular Complex in Pancreatic Cancer: A Potential Therapeutic Target in Tumor GrowthTranslational Oncology, 2013
- Effects of EdU labeling on mesenchymal stem cellsCytotherapy, 2013
- The effects of pentoxifylline on lung inflammation in a rat model of meconium aspiration syndromeExperimental Lung Research, 2012
- Leukotriene B4 Receptor-1 Mediates Intermittent Hypoxia-induced AtherogenesisAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Effect of chronic intermittent hypoxia on biological behavior and hypoxia‐associated gene expression in lung cancer cellsJournal of Cellular Biochemistry, 2010